Answers are grounded in this paper and cite their sources.
Demonstrates that factor VIII residue K2239 mediates protein S binding independently of activated protein C, highlighting a distinct regulatory mechanism in blood coagulation.
Background: We demonstrated that protein S (PS) directly impairs the intrinsic tenase complex, independent of activated protein C (APC), by competitively inhibiting the binding of factor (F)IXa to the A2 domain (residues 488-490) and light chain (LCh) of FVIIIa. Objectives: This study investigated the PS-binding sites within the FVIII-LCh subunit. Methods: Binding interactions between PS and the FVIII-LCh were characterized using ELISA, a synthetic C2-domain peptide (residues 2228-2240), and surface plasmon resonance. The interacting residue was examined using 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride-mediated crosslinking and N-terminal sequencing. The functional role of the identified site (K2239) was evaluated using recombinant FVIII mutants and FXa generation assays assessing sensitivity to PS-mediated and APC/PS-mediated inhibition. This effect was additive with mutations in the previously identified A2-domain site (S488A/R489A/R490A). Importantly, while the A2 site contributed to APC/PS-dependent inactivation, the contribution of K2239 to this process appeared limited, suggesting a more prominent role in the APC-independent pathway. Conclusion: Factor VIII residues 488 to 490 and 2239 participate in APC-independent interaction with PS, while residues 488 to 490 also contribute to the APC/PS-dependent inactivation of FVIIIa.
No takes yet. Share an insight, caveat, or question.
Furukawa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: